Story thread · 3 reports / 1 sources
Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
financialpost.com · 11d
TORONTO and HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer, autoimmune, and inflammatory diseases, announced today that Dr. Fahar Merchant, President and CEO of Medicenna, will present and participate in one-on-one meetings at […]
First report: Orion Digital to Participate in H.C. Wainwright’s 28th Annual Global Investment Conference — financialpost.com, 13d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.